Annual General Meeting 2012
The Annual General Meeting ("AGM") in Aerocrine AB (publ) will be held on Thursday May 3, 2012, 5.00 p.m. CET at the offices of Mannheimer Swartling Advokatbyrå, Norrlandsgatan 21 in Stockholm.
Minutes Annual General Meeting 2012 (pdf-file)
Articles of association 3 May 2012 (pdf-file)
Notice of Annual General Meeting (pdf-file)
Proposal and motivated statement from the Nomination Committee (pdf-file)
Information on proposed Board members (pdf-file)
Form of proxy (pdf-file)
Proposal by the Board of Directors of Aerocrine AB on authorization for the Board of Directors to resolve on new share issues (pdf-file)
Proposal by the Board of Directors of Aerocrine AB to amend the Articles of Association (pdf-file)
Articles of association - appendix to Board proposal (pdf-file)
Proposal on guidelines for remuneration to senior management (pdf-file)
Proposal on the adoption of a Board member share plan (pdf-file)
Appendix to the proposal on the adoption of a Board member share plan (pdf-file)
The Board's report of the Remuneration Committee's evaluation of remuneration (pdf-file)
Extra General Meeting April 10, 2012/New share issue
Important Information
Electronic versions of the materials you are seeking to access are being made available on this webpage by Aerocrine AB (publ) ("Aerocrine") in good faith and for information purposes only.
These materials are not directed at or accessible by persons located in the United States, Canada, Australia, Hong Kong, Singapore, South Africa, Japan or New Zealand.
Please read this notice carefully – it applies to all persons who view this webpage. Please note that the disclaimer set out below may be altered or updated. You should read it in full each time you visit the webpage.
Overseas Persons
Viewing the materials you seek to access may not be lawful in certain jurisdictions. In other jurisdictions, only certain categories of person may be allowed to view such materials. Any persons who wish to view these materials must first ensure themselves that they are not subject to any local requirements that prohibit or restrict them from doing so.
In particular, unless otherwise determined by Aerocrine and permitted by applicable law and regulation, it is not intended, subject to certain exceptions, that any offering of the securities (the "Securities") mentioned in such materials by Aerocrine would be made, or any documentation be sent, directly or indirectly, in or into, the United States, Canada, Australia, Hong Kong, Singapore, South Africa, Japan or New Zealand.
The materials do not constitute or form a part of any offer or solicitation to purchase or subscribe for the Securities in any jurisdiction or jurisdictions in which such offers or sales are unlawful prior to registration or qualification under the securities laws of any such jurisdiction. The rights issue is not directed to shareholders or other investors domiciled in the United States, Canada, Australia, Hong Kong, Singapore, South Africa, Japan or New Zealand, or in any other country where participation in the issue would require additional prospectuses, registration or other measures other than those pursuant to Swedish law or would conflict with regulations in such country. No shares, interim shares, subscription rights or other securities issued by Aerocrine have been or will be registered in accordance with the United States Securities Act of 1933, or in accordance with any securities legislation in any state of the United States or any province in Canada. Accordingly, no new shares, interim shares, subscription rights or other securities issued by Aerocrine may be transferred or offered for sale in the United States or Canada, other than in such exceptional cases that do not require registration. The rights issue is directed only at (i) persons who are outside the United Kingdom; or (ii) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended); or (iii) persons to whom it can otherwise lawfully be directed at.
If you are not permitted to view materials on this webpage or if you are in any doubt as to whether you are permitted to view these materials, please exit this webpage.
Basis of access
Access to electronic versions of these materials is being made available on this webpage by Aerocrine in good faith and for information purposes only. Any person seeking access to this webpage represents and warrants to Aerocrine that they are doing so for information purposes only. Making press announcements and other documents available in electronic format does not constitute an offer to sell or the solicitation of an offer to buy securities in Aerocrine. Further, it does not constitute a recommendation by Aerocrine or any other party to sell or buy Aerocrine securities.
Use the links below to indicate in which country you are resident:
United States, Canada, Australia, Hong Kong, Singapore, South Africa, Japan, New Zealand
Sweden, or rest of the world
Notice of Extraordinary General Meeting 16 November 2011
An Extraordinary General Meeting (“EGM”) in Aerocrine AB is held on Wednesday 16 November 2011 at 5.00 p.m. CET at the offices of Mannheimer Swartling Advokatbyrå, Norrlandsgatan 21 in Stockholm.
Notice (pdf-file)
Form of proxy (pdf-file)
CV new proposed board member (pdf-file)
Board report on events of material significance (pdf-file)
Proposal by the Board of Directors of Aerocrine AB on (A.) the implementation of a long-term incentive program,
and (B.) the issuance and approval of transfer of warrants (pdf-file)
Terms and conditions for warrants (pdf-file)
Annual General Meeting 5 May
The Annual General Meeting of Aerocrine AB was held at 5.00 pm on Thursday, 5 May 2011 in Mannheimer & Swartlings facilities on Norrlandsgatan 21 in Stockholm, Sweden.
Pdf-files:
Minutes AGM 2011
Notice of Annual General Meeting
Form of proxy
Proposal and statement from the Nomination Committee in Aerocrine AB
for the 2011 Annual General Meeting
Information on proposed Board members at the 2011 Annual General Meeting
Proposal by the Board of Directors of Aerocrine AB on guidelines for salary
and other remuneration to senior management
Proposal by the Board of Directors of Aerocrine AB to amend the Articles of
Association
Proposal by the Board of Directors of Aerocrine AB on a resolution on authorization to the Board of Directors to resolve on new share issues and to issue convertible bonds and share option rights
The Board of Directors' report of the Remuneration Committee's evaluation of remunerations to senior executives